Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 1
1975 1
1976 2
1978 1
1979 2
1980 3
1982 2
1983 1
1984 1
1985 1
1986 1
1987 3
1988 1
1989 11
1990 4
1991 4
1992 5
1993 8
1994 6
1995 12
1996 6
1997 16
1998 20
1999 14
2000 15
2001 19
2002 19
2003 23
2004 17
2005 24
2006 29
2007 37
2008 25
2009 57
2010 41
2011 43
2012 89
2013 36
2014 94
2015 58
2016 72
2017 56
2018 56
2019 31
2020 46
2021 61
2022 51
2023 56
2024 53

Text availability

Article attribute

Article type

Publication date

Search Results

1,132 results

Results by year

Filters applied: . Clear all
Page 1
Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, Sassaki LY. Quaglio AEV, et al. World J Gastroenterol. 2022 Aug 14;28(30):4053-4060. doi: 10.3748/wjg.v28.i30.4053. World J Gastroenterol. 2022. PMID: 36157114 Free PMC article. Review.
Dysbiosis, characterized by an imbalance between the beneficial and opportunistic gut microbiota, is associated with several gastrointestinal disorders, such as irritable bowel syndrome (IBS); inflammatory bowel disease (IBD), represented by ulcerative …
Dysbiosis, characterized by an imbalance between the beneficial and opportunistic gut microbiota, is associated with several gastrointestina …
Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Ahmed W, Galati J, Kumar A, Christos PJ, Longman R, Lukin DJ, Scherl E, Battat R. Ahmed W, et al. Clin Gastroenterol Hepatol. 2022 Mar;20(3):e361-e379. doi: 10.1016/j.cgh.2021.03.034. Epub 2021 Mar 31. Clin Gastroenterol Hepatol. 2022. PMID: 33798711 Review.
BACKGROUND AND AIMS: We conducted a systematic review and meta-analysis to summarize emerging data on the safety and effectiveness of dual biologic therapy in combination or with tofacitinib in patients with refractory inflammatory bowel disease (IBD). METHOD …
BACKGROUND AND AIMS: We conducted a systematic review and meta-analysis to summarize emerging data on the safety and effectiveness of dual b …
Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease.
Sakurai T, Saruta M. Sakurai T, et al. Digestion. 2023;104(1):30-41. doi: 10.1159/000527846. Epub 2022 Nov 18. Digestion. 2023. PMID: 36404714 Free PMC article. Review.
BACKGROUND: Mucosal healing (MH) was proposed to be an ideal treatment goal for patients with inflammatory bowel disease (IBD). Instead of endoscopy to confirm MH, biomarkers are frequently used and have become an indispensable modality for the clinical exami …
BACKGROUND: Mucosal healing (MH) was proposed to be an ideal treatment goal for patients with inflammatory bowel disease …
A comprehensive review and update on Crohn's disease.
Gajendran M, Loganathan P, Catinella AP, Hashash JG. Gajendran M, et al. Dis Mon. 2018 Feb;64(2):20-57. doi: 10.1016/j.disamonth.2017.07.001. Epub 2017 Aug 18. Dis Mon. 2018. PMID: 28826742 Review.
The term inflammatory bowel disease (IBD) refers principally to two major categories of chronic relapsing inflammatory intestinal disorders: Crohn's disease (CD) and ulcerative colitis (UC). ...Endoscopic scores are considered to be the gold sta …
The term inflammatory bowel disease (IBD) refers principally to two major categories of chronic relapsing inflammato …
Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease.
Din S, Selinger CP, Black CJ, Ford AC. Din S, et al. Aliment Pharmacol Ther. 2023 Mar;57(6):666-675. doi: 10.1111/apt.17379. Epub 2022 Dec 31. Aliment Pharmacol Ther. 2023. PMID: 36585944 Free article. Review.
BACKGROUND: Biologics and small molecules for inflammatory bowel disease (IBD) may increase infection risk. Herpes zoster causes acute and long-term symptoms, but vaccination is not recommended in patients with IBD, unless >50 years of age. ...RESULTS: We …
BACKGROUND: Biologics and small molecules for inflammatory bowel disease (IBD) may increase infection risk. Herpes zost …
Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD.
Martyniak A, Medyńska-Przęczek A, Wędrychowicz A, Skoczeń S, Tomasik PJ. Martyniak A, et al. Biomolecules. 2021 Dec 18;11(12):1903. doi: 10.3390/biom11121903. Biomolecules. 2021. PMID: 34944546 Free PMC article. Review.
The increasing incidence of inflammatory bowel diseases (IBD) and the increasing severity of the course of these diseases create the need for developing new methods of therapy. ...
The increasing incidence of inflammatory bowel diseases (IBD) and the increasing severity of the course of these dis …
Exosome-Induced Regulation in Inflammatory Bowel Disease.
Zhang H, Wang L, Li C, Yu Y, Yi Y, Wang J, Chen D. Zhang H, et al. Front Immunol. 2019 Jun 28;10:1464. doi: 10.3389/fimmu.2019.01464. eCollection 2019. Front Immunol. 2019. PMID: 31316512 Free PMC article. Review.
An exosome (30-150 nm size) is a cell-derived vesicle. Exosome-induced regulation in inflammatory bowel disease (IBD) is becoming increasingly popular due to their potential functions of exosomal pathways. ...
An exosome (30-150 nm size) is a cell-derived vesicle. Exosome-induced regulation in inflammatory bowel disease …
Mild Crohn's Disease: Definition and Management.
Claytor J, Kumar P, Ananthakrishnan AN, Colombel JF, Agrawal M, Ungaro RC. Claytor J, et al. Curr Gastroenterol Rep. 2023 Mar;25(3):45-51. doi: 10.1007/s11894-023-00863-y. Epub 2023 Feb 8. Curr Gastroenterol Rep. 2023. PMID: 36753033 Review.
PURPOSE OF REVIEW: Crohn's Disease (CD) is a chronic inflammatory disease that can lead to progressive damage to the gastrointestinal tract and significant disability. Early, "top-down" biologic therapy is recommended in moderate-to-severe CD to induce remiss …
PURPOSE OF REVIEW: Crohn's Disease (CD) is a chronic inflammatory disease that can lead to progressive damage to the ga …
Acute Severe Ulcerative Colitis: Optimal Strategies for Drug Therapy.
Nakase H. Nakase H. Gut Liver. 2023 Jan 15;17(1):49-57. doi: 10.5009/gnl220017. Epub 2022 Nov 14. Gut Liver. 2023. PMID: 36375793 Free PMC article. Review.
Acute severe ulcerative colitis (ASUC) is a life-threatening medical emergency with considerable morbidity (30% to 40%). Patients with ASUC require hospitalization for prompt medical treatment, and colectomy is considered if medical therapy fails. ...In addition, risk stra …
Acute severe ulcerative colitis (ASUC) is a life-threatening medical emergency with considerable morbidity (30% to 40%). Patients wit …
Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies.
Bhat S, Click B, Regueiro M. Bhat S, et al. Inflamm Bowel Dis. 2024 May 2;30(5):829-843. doi: 10.1093/ibd/izad120. Inflamm Bowel Dis. 2024. PMID: 37450619 Review.
The recent approval of new medications with novel mechanisms of action and emergence of updated safety information for existing therapies has changed the treatment landscape of inflammatory bowel disease (IBD). These advances led to unique adverse effect prof …
The recent approval of new medications with novel mechanisms of action and emergence of updated safety information for existing therapies ha …
1,132 results